SCHEMBL6784015

SCHEMBL6784015

CCCCOc1ccc(N(C)CCC2(O)CCN(CC(O)c3ccc(F)cc3)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.41
HTR2A P28223 2/20 0.41
HRH1 P35367 2/20 0.41
KDM4E B2RXH2 2/20 0.40
SLC6A4 P31645 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
HTR1A P08908 1/20 0.38
DRD1 P21728 1/20 0.38
DRD5 P21918 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR7 P34969 1/20 0.38
DRD3 P35462 1/20 0.38
HTR2B P41595 1/20 0.38
MMP1 P03956 1/20 0.38
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38
HTT P42858 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.36
IGF1R P08069 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6783674 0.99 DRD2 (0.40) DRD2HTR2AHRH1KDM4ESLC6A4
SCHEMBL6785995 0.91 KMT2A (0.43) DRD2HTR2AHRH1KDM4EMAPT
Hydrochloric Acid SCHEMBL6790394 0.90 KMT2A (0.45) DRD2HTR2AHRH1KDM4EMAPT
SCHEMBL7224307 0.87 KDM4E (0.41) DRD2HTR2AHRH1KDM4EHTT
Hydrochloric Acid SCHEMBL7229657 0.86 KDM4E (0.41) DRD2HTR2AHRH1KDM4ESLC6A2
SCHEMBL6783660 0.85 MMP1 (0.52) HRH3MMP1MMP9MMP13KMT2A
Hydrochloric Acid SCHEMBL6783396 0.84 MMP1 (0.52) HRH3MMP1MMP9MMP13KMT2A
SCHEMBL6791086 0.83 HTR2A (0.43) DRD2HTR2AHRH1SLC6A4HRH3
Hydrochloric Acid SCHEMBL6785753 0.82 HTR2A (0.42) DRD2HTR2AHRH1SLC6A4HRH3
SCHEMBL6789871 0.81 ALDH1A1 (0.46) DRD2HTR2AHRH1HRH3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6710060-B2 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2004-03-23 US disclosed
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-12-12 US disclosed
EP-1182192-A1 4-HYDROXYPIPERIDINE DERIVATIVES HAVING ANTIARRHYTHMIC EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity SCN5A, RYR2, SCN1B DRD2 152/4885HTR2A 932/4885HRH1 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.